Summary
A questionnaire survey based on hypertension case histories was performed among a representative sample of 400 GP's and hospital doctors in Northern Ireland, Norway and Sweden, countries having markedly different utilization of antihypertensive drugs. We found a greater propensity to start antihypertensive drug treatment in Northern Ireland than in Norway and Sweden. This was true both in mild diastolic and isolated systolic hypertension. Yet the utilization of antihypertensive drugs in Sweden is about 60% higher than in Northern Ireland and 30% higher than in Norway. Swedish physicians preferred beta-blockers as their first choice to a greater extent than physicians in Northern Ireland and Norway who selected thiazides more often. In general, the choice of drugs agreed with the sales and prescribing patterns in the three countries.
Besides providing more insight in therapeutic traditions the study indicates that the lower prescribing of antihypertensive drugs in Northern Ireland, and to some extent in Norway, compared to Sweden, might be due to differences in true or apparent morbidity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lunde PKM (1976) Differences in national drug-prescribing patterns. In: Clinical pharmacological evaluation in drug control. Report on a symposium, Deidesheim, 1975. World Health Organization. Regional Office of Europe, Copenhagen, pp 19–47
Baksaas I (1984) Patterns in drug utilization — national and international aspects: Antihypertensive drugs. Acta Med Scand 683 [Suppl]: 59–66
WHO-Drug Utilization Research Group (DURG) (1985) Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol 30: 513–519
WHO-Drug Utilization Research Group (DURG) (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden. I. Diabetes. Eur J Clin Pharmacol 30: 513–519
Yeomans KA (1976) Applied statistics, statistics for the social scientist: 2 Penguin education. Penguin Books Ltd, Harmondsworth, Middlesex, England, pp 51–53 and 94–97
Coope J (1984) Hypertension in general practice: What is to be done? Br Med J 288: 880–881
Bergman U, Manell P, Wessling A (1983) Treatment of hypertension in the elderly. Patterns of drug utilization in Sweden. In: Workshop, treatment of hypertension in the elderly. National Board of Health and Welfare. Drug Information Committee, Sweden, pp 113–121, (1983) 4
Hypertension Detection and Follow-up Programm Cooperative Group (1979) Five-years findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Am Med Assoc 242: 2562–2571
The Australian Therapeutic Trial in Mild Hypertension. The Management Committee. Lancet (1980) 1, 1261–1267
Helgeland A (1980) Treatment of mild hypertension: A five year controlled drug trial. The Oslo Study. Am J Med 69: 725–732
Multiple Risk Factor Intervention Trial Research Group (1982) Multiple risk factor intervention trial. Risk factor changes and mortality results. J Am Med Assoc 248: 1465–1477
Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension principal results. Br Med J 291: 97–104
Kannel WB, Gordon T, Schwartz M (1971) Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham Study. Am J Cardiol 27: 335–346
Holme I, Waaler HT (1976) Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. Acta Med Scand 200: 229–239
The Norwegian Multicenter Study Group (1981) Timolo-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801–807
Hjalmarson Å, Elmfeldt D, Holberg S, Rydén L, Svedberg K, Vedin A, Waagstein F, Waldenström J, Wedel H, Wilhelmsen L, Wilhelmsson C (1983) The Göteborg Metoprolol Trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation 67: [Suppl 1]: 229–239
Beta-Blocker Heart Attack Trial Research Group (1982) A randomized trial of propranolol in patients with acute myocardial infarction. J Am Med Assoc 247: 1707–1714
Berglund G, Wilhelmsen L, Sannerstedt R, Hansson L, Andersson O, Silvertsson R, Wedel H, Wikstrand J (1978) Coronary heart-disease after treatment of hypertension. Lancet 1: 1–5
Wilhelmsen L, Berglund G, Elmfeldt D, Wedel H (1981) Beta-blockers versus saluretics in hypertension. Comparison of total mortality, myocardial infarction and sudden death. Study design and early results on blood pressure reduction. Prev Med 10: 38–49
Ames RP, Hill P (1976) Elevation of serum lipid levels during diuretic therapy of hypertension. Am J Med 61: 748
Leren P, Helgeland H, Holme I, Foss PO, Hjermann I, Lund-Larsen PG (1980) Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet 2: 4–6
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
WHO Drug Utilization Research Group (DURG)., Griffiths, K., McDevitt, D.G. et al. Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. Eur J Clin Pharmacol 30, 521–525 (1986). https://doi.org/10.1007/BF00542409
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542409